AN2 Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
AN2 Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2021 to Q3 2024.
  • AN2 Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 29.9M shares, a 0.43% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 29.9M +127K +0.43% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 29.8M +7.9M +36% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 29.8M +10.4M +53.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 29.7M +10.3M +53.3% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 29.7M +10.3M +53.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 21.9M +2.53M +13% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 19.4M +714K +3.81% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 19.4M +16.7M +611% Dec 31, 2022 10-K 2024-03-29
Q3 2022 19.4M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 19.4M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 18.7M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 2.73M Dec 31, 2021 10-K 2023-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.